2.50
Hdl Handle:
http://hdl.handle.net/10755/165030
Category:
Abstract
Type:
Presentation
Title:
QUALITY OF LIFE IN PATIENTS WITH PROSTATE CANCER: A CLINICIAN DRIVEN STUDY
Author(s):
Kratz, Melissa; Kimmel, Sharon
Author Details:
Melissa Kratz, RN MSN AOCN, Oncology Clinical Nurse Specialist, Lehigh Valley Hospital and Health Network, Allentown, Pennsylvania, USA, email: melissa.kratz@lvh.com; Sharon Kimmel, PhD
Abstract:
Men diagnosed with prostate cancer (PC) face a unique challenge in choosing a curative therapy that may significantly affect post treatment quality of life (PT-QOL). There are limited studies that examine PT-QOL compared by PC therapy: radical prostatectomy, external beam radiation therapy (EBRT) and brachytherapy. As clinicians who coordinate multidisciplinary second-opinion consultations, we guide patients in their decision-making process. Study purpose is to identify and better understand the patients' PT- QOL experience across various curative therapies. Study is done in 2 phases: phase 1 investigates prevalence and PT-QOL indicators of patients presenting with localized PC to this institution. Phase 2 includes a functional assessment of the patientÆs experienced PT- QOL issues. The patient participation in decision making model was utilized. A functional assessment of cancer therapy and PT-QOL questionnaire will be distributed in Phase II. Purpose of the questionnaire is to better understand the patientsÆ experiences. Questionnaires will be employed and may be modified based on issues identified from a focus group of prostate cancer survivors. Phase I: 552 men were treated during 2004-2005. Mean age 68 +/- 9 years, 92% white, 84% married. 84% (462) were diagnosed Stage2, 8% (43) Stage3, 7% (41) Stage4 and 1% (6) stage unknown. Total- follow-up months 7916 (mean 14.6 +/- 8.8). 95% (524) alive at last contact. Treatment breakdown: 49% (270/552) underwent radiation treatment (RT); 70% (189/270) EBRT, 28% (75/270) Brachytherapy. 42% (232/552) underwent surgery. RT patients were older (70.5¦8 years) than Surgical (65 +/- 9). (p<0.001) There was no statistically significant difference in Gleason scoring between the two groups. It is anticipated the outcome of this study will be used to develop interventions designed to guide patients in their curative-therapy decision making-process and better prepare patients to anticipate and manage real and perceived PT-QOL issues.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2007
Conference Name:
32nd Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Las Vegas, Nevada, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleQUALITY OF LIFE IN PATIENTS WITH PROSTATE CANCER: A CLINICIAN DRIVEN STUDYen_GB
dc.contributor.authorKratz, Melissaen_US
dc.contributor.authorKimmel, Sharonen_US
dc.author.detailsMelissa Kratz, RN MSN AOCN, Oncology Clinical Nurse Specialist, Lehigh Valley Hospital and Health Network, Allentown, Pennsylvania, USA, email: melissa.kratz@lvh.com; Sharon Kimmel, PhDen_US
dc.identifier.urihttp://hdl.handle.net/10755/165030-
dc.description.abstractMen diagnosed with prostate cancer (PC) face a unique challenge in choosing a curative therapy that may significantly affect post treatment quality of life (PT-QOL). There are limited studies that examine PT-QOL compared by PC therapy: radical prostatectomy, external beam radiation therapy (EBRT) and brachytherapy. As clinicians who coordinate multidisciplinary second-opinion consultations, we guide patients in their decision-making process. Study purpose is to identify and better understand the patients' PT- QOL experience across various curative therapies. Study is done in 2 phases: phase 1 investigates prevalence and PT-QOL indicators of patients presenting with localized PC to this institution. Phase 2 includes a functional assessment of the patient&AElig;s experienced PT- QOL issues. The patient participation in decision making model was utilized. A functional assessment of cancer therapy and PT-QOL questionnaire will be distributed in Phase II. Purpose of the questionnaire is to better understand the patients&AElig; experiences. Questionnaires will be employed and may be modified based on issues identified from a focus group of prostate cancer survivors. Phase I: 552 men were treated during 2004-2005. Mean age 68 +/- 9 years, 92% white, 84% married. 84% (462) were diagnosed Stage2, 8% (43) Stage3, 7% (41) Stage4 and 1% (6) stage unknown. Total- follow-up months 7916 (mean 14.6 +/- 8.8). 95% (524) alive at last contact. Treatment breakdown: 49% (270/552) underwent radiation treatment (RT); 70% (189/270) EBRT, 28% (75/270) Brachytherapy. 42% (232/552) underwent surgery. RT patients were older (70.5&brvbar;8 years) than Surgical (65 +/- 9). (p&lt;0.001) There was no statistically significant difference in Gleason scoring between the two groups. It is anticipated the outcome of this study will be used to develop interventions designed to guide patients in their curative-therapy decision making-process and better prepare patients to anticipate and manage real and perceived PT-QOL issues.en_GB
dc.date.available2011-10-27T12:11:16Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:11:16Z-
dc.conference.date2007en_US
dc.conference.name32nd Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationLas Vegas, Nevada, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.